An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol

Abstract Background Gonorrhoea is an ongoing public health concern due to its rising incidence and the emergence of antibiotic resistance. There are an estimated 82 million new Neisseria gonorrhoeae infections each year, with several populations at higher risk for gonococcal infection, including gay...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Caroline Thng, Evgeny A. Semchenko, Ian Hughes, Maree O’Sullivan, Kate L. Seib
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2023-03-01
Sarja:	BMC Public Health
Aiheet:	Gonorrhoea Neisseria gonorrhoeae Sexually transmitted infection (STI) Gay and bisexual men (GBM) Men who have sex with men (MSM) 4CMenB
Linkit:	https://doi.org/10.1186/s12889-023-15516-y
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!